Established in 2001 by Rose-Lee and Keith Reinhard
Keith and Rose-Lee Reinhard pictured with Dr. Patrick Walsh (middle), University Distinguished Service Professor of Urology
ROSE-LEE and KEITH REINHARD, New Yorkers who are active in civic affairs, are determined to improve prostate cancer diagnosis and treatment. Mr. Reinhard is chairman emeritus of DDB Worldwide, the largest advertising agency in the U.S. and third largest in the world. Motivated by the fact that the disease runs in families, the couple has become deeply interested in Hopkins research on hereditary prostate cancer. They decided to endow this professorship so that perhaps their sons, grandsons, and other young men at risk for developing the disease might benefit from earlier detection. Mr. Reinhard is a member of the Brady Urological Advisory Council.
“I have noticed at Johns Hopkins Medicine this fiery passion and commitment to the mission of seeking answers and saving lives. You can feel it. Johns Hopkins Medicine has a large dream: to eradicate disease from the earth.”
-Keith Reinhard
Held by Tamara Lotan
TAMARA LOTAN, M.D., is a Professor of Pathology, Urology, and Oncology and Deputy Director for Research in the Department of Pathology at Johns Hopkins University School of Medicine in Baltimore, Maryland. She completed her undergraduate degree at Harvard University (Applied Mathematics), followed by medical school and Anatomic Pathology Residency at the University of Chicago. After a fellowship in Urology Pathology at Johns Hopkins, she joined the faculty there in 2008 as a physician-scientist focusing on the molecular pathology of genitourinary tumors. Her NIH- and DoD-funded laboratory works on in situ prognostic and predictive molecular biomarkers for prostate cancer using human tissue specimens, developing genetically validated markers that have been transitioned into routine clinical use. Her group also focuses on the role of ancestry in prostate cancer molecular subtype prevalence, integrating molecular pathology into prostate cancer health disparities research. Finally, in more basic work, the lab studies the role of mTORC1 signaling in epithelial morphogenesis and tumorigenesis using mouse models, with a focus on renal cell carcinoma. Clinically, Dr. Lotan serves as one of three faculty members covering the Urologic pathology consultation service, which is among the busiest in the world examining challenging genitourinary pathology cases. In addition to her research and clinical efforts, Dr. Lotan co-leads the Hopkins Department of Pathology T32 training grant, as well as the Hopkins Clinician-Scientist Award Program which provides bridge funding to junior physician-scientist faculty across the institution. Finally, with the Director of the Brady Urological Institute at Hopkins, she co-directs the Schaufeld Program for Prostate Cancer in Black Men, where she leads a post-baccalaureate training program for aspiring physicians from backgrounds under-represented in science and medicine.
